Browsing: COVID-19

The role of corticosteroids in severe infections, sepsis and ARDS has been a constantly evolving discussion and remains controversial. The recent APROCCHSs, ADRENAL and DEXA-ARDS along with other prio
The STAAMP Trial results show TXA, with a thus far demonstrated low adverse event rate, should be considered in all trauma patients as early as feasibly possible, and those with more severe forms of s
COVID-19 has brought a lot of negatives and challenges, so I will look for and take a positive wherever I can find it. One bright note this year: Pet adoptions are on the rise as people realize the he
The COVID-19 pandemic has wrought havoc on life as we know it, and with that has come an overwhelming collective negativity. Although the damage that COVID-19 has done cannot be minimized, it makes it
Since the coronavirus pandemic, emergency departments across the country have been experiencing lower volumes and higher acuity - including new cancer diagnoses in the ED.
As SARS-CoV-2 spreads globally, physicians are turning to different imaging modalities to assist in the diagnosis of COVID-19 and risk stratification of patients. Along with clinical suspicion, chest
While the treatment for SARS-CoV-2 continues to evolve, the emergency department remains a primary place for early medical intervention. There is growing evidence to support that initiating steroids w
A complex trial meant to determine whether hydrocortisone can improve outcomes for patients with severe COVID-19 was stopped early - but still shows promise for the course.
With no clear consensus on the use of steroids in critically ill sepsis patients, a recent meta-analysis studies the 28-day mortality in critically ill COVID-19 patients when corticosteroids are admin